Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment

Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment

The oral delivery strategy of natural anti-oxidant and anti-inflammatory agents has attracted great attention to improve the effectiveness of ulcerative colitis (UC) treatment. Herein, we developed a novel orally deliverable nanoparticle, carboxymethyl chitosan (CMC)-modified astaxanthin (AXT)-loade...

Full description

Bibliographic Details
Main Authors: Wen Zhang, Xinping Zhang, Xinyi Lv, Ao Qu, Wenjing Liang, Limin Wang, Pei Zhao, Zijian Wu
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Molecules
Subjects:
astaxanthin
carboxymethyl chitosan
nanoparticle
anti-inflammatory
ulcerative colitis
Online Access:https://www.mdpi.com/1420-3049/29/6/1291

Internet

https://www.mdpi.com/1420-3049/29/6/1291

Similar Items